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MicroRNAs (miRNAs) participate in a variety of functions in the brain. Understanding the in
vivo localization of miRNAs is an important step for uncovering their roles in brain function.
However, the in situ detection of low-abundance miRNAs in brain tissues remains difficult
and requires extensive optimization of in situ hybridization (ISH) protocols in individual
laboratories. Thus, detailed information regarding experimental conditions would serve as
a useful reference for researchers in this field. Here, we investigated and summarized the
effects of adjusting a series of critical steps, including tissue fixation, probe accessibility
and hybridization stringency, to standardize the currently used miRNA ISH procedures.
As a result, we successfully detected several low-abundance miRNAs by ISH using the
following experimental conditions: (1) use of fresh brain tissues, (2) digestion of brain
samples with proteinase K, (3) LNA-probe hybridization at a temperature 37◦C below the
melting temperature of the RNA, (4) performance of high-stringency wash steps using
50% formamide in 1× standard saline citrate (SSC) buffer. RT-PCR of the punched-out
tissues using TaqManTM primers confirmed the ISH results. Finally, double-fluorescence
ISH successfully demonstrated the colocalization of miRNAs and mRNAs. Thus, the
detailed information regarding the miRNA ISH procedures used in this study may help
to resolve the technical hurdles observed in the in vivo localization of miRNAs, and the
elucidation of the specific roles of miRNAs.
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INTRODUCTION
MicroRNAs (miRNAs) serve as post-transcriptional fine-tuners of gene expression (Meister,
2007), and have become a focus of interest in both basic and translational neuroscience research
(Soreq, 2014). A detailed spatial expression analysis of miRNAs in brain tissue is an important
step to elucidate their functions. A powerful tool for studying miRNA localization is in situ
hybridization (ISH), which uses 2′-O, 4′-C-methylene bridged nucleic acid/locked nucleic acid
(LNA; Torigoe et al., 2001) probes that have an increased melting temperature (Tm) and provide
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enhanced stringency with short probes (Kloosterman et al.,
2006). Several miRNA ISH protocols have been reported
(Thompson et al., 2007; Obernosterer et al., 2007; Jørgensen
et al., 2010; Chaudhuri et al., 2013). Pena et al., reported
in situ localization of 48 out of 126 miRNAs (Pena et al.,
2009). ISH reliably detects high-abundance miRNAs, such
as miR-124, in brain tissues (Sanuki et al., 2011), whereas
detection of low-abundance miRNAs in brain tissues still proves
difficult and requires extensive optimization in each laboratory.
Therefore, this article provides detailed information regarding
the experimental conditions tested in our laboratory, which may
serve as a useful reference for researchers in this field.
The specificity and sensitivity of the ISH signals are highly
dependent on the stringency of the hybridization, which is
determined by the thermal stability of the probes and the
concentration of formamide used in the hybridization and
post-wash buffers (Obernosterer et al., 2007). In addition to
these conditions, sample fixation, or probe accessibility can also
influence the degree of signal intensity. The present study was
designed to investigate the effects of a series of critical procedures,
including the following: (1) tissue fixation, (2) proteinase K
treatment, (3) hybridization temperature, and (4) stringent
washes. Using this optimized protocol, we detected the ISH
signals specific to several miRNAs, whose expression patterns are
unknown. Moreover, the optimized miRNA ISH protocol can be
used with mRNA ISH to identify cell-type specific expression of
miRNAs. Thus, our study contributes to the field by enhancing
the robustness of the miRNA ISH technique.
MATERIALS AND EQUIPMENT
Animals
All animal care and handling procedures were performed
according to the Guiding Principles for the Care and Use of
Laboratory Animals, approved by the Animal Care and Use
Committee of the Graduate School of Pharmaceutical Sciences,
Osaka University, Japan. Male 7–8 week old C57BL/6J mice were
purchased from Shimizu Laboratory Supplies (Kyoto, Japan). The
mice were kept on a 12 h light/dark cycle (lights on at 8:00 a.m.)
and in a controlled room (temperature 22–24◦C). Food andwater
were available ad libitum.
Equipment Used for ISH
Cryostat (CM1520, Leica, Wetzlar, Germany).
Hybridization oven (HB-80, TAITEC, Saitama, Japan) and/or
Hybridizer (S2450, DAKO Denmark A/S, Glostrup, Denmark).
Fluorescence microscope (BZ-9000, KEYENCE, Osaka,
Japan).
Buffers and Solutions
Ensure that all equipment and working surfaces remain RNase-
free by using RNase Away (Molecular BioProducts, San Diego,
CA) or dry heat sterilization at 200◦C for at least 5 h.
The following buffers or solutions can be prepared in advance.
1. 10× phosphate buffered saline (PBS), pH 7.38
30 g of NaCl.
1 g of KCl.
12 g of Na2HPO4•12H2O.
1 g of KH2PO4.
Make up to 500 mL with ultrapure water which has
been RNase-inactivated by diethyl pyrocarbonate (DEPC)
treatment.
Store at room temperature.
Note: DEPC treatment
Add 1 mL of DEPC per 1 L of solution (0.1% v/v).
Incubate at room temperature for 1 h and autoclave at 121◦C
for 20 min.
2. 12% paraformaldehyde (PFA)
60 g of PFA.
Make up to 500 mL with 1× PBS.
Store at−20◦C and protect from light.
Dilute 12% PFA with PBS to 4% PFA on the day of the
experiment.
Store in aliquots at−30◦C.
3. 20× standard saline citrate (SSC), pH 7.0
175 g of NaCl.
88.2 g of trisodium citrate dehydrate.
Make up to 1000 mL with ultrapure water.
Adjust pH with 1 M HCl and treat the solution with DEPC.
Store at room temperature.
4. Hybridization buffer
25 mL of deionized formamide.
0.5 mL of 1 M Tris-HCl, pH 7.2.
5 mL of 20× SSC.
1 mg/mL of yeast tRNA.
10mg of sodium dodecyl sulfate (SDS).
10 mL of 50% dextran sulfate.
1 mL of 50× Denhardt’s solution.
Make up to 50 mL with ultrapure water.
Store in aliquots at−20◦C.
5. 10× Tris-HCl, NaCl (TN) buffer, pH7.3
13.4 g of Trizma base.
140 g of Trizma hydrochloride.
87.7 g of NaCl.
Make up to 1000 mL with ultrapure water.
Store at room temperature.
6. 10×maleic acid buffer, pH 7.5
58.1 g of maleic acid.
43.8 g of NaCl.
Adjust pH using NaOH.
Make up to 500 mL with ultrapure water.
Store at room temperature.
7. 1 M Tris-HCl, pH 9.5
Dissolve 121 g of Trizma base in 900 mL of ultrapure water.
Adjust pH using 12 M HCl.
Store at room temperature.
8. 10× PBS, pH 5.8
40.0 g of NaCl.
1.0 g of KCl.
13.6 g of Na2HPO4•12H2O.
42.3 g of NaH2PO4•2H2O.
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Make up to 500 mL with ultrapure water.
Store at room temperature.
9. 0.2 M phosphate buffer, pH 7.0
4.4 g of Na2HPO4•12H2O.
1.2 g of NaH2PO4•2H2O.
Make up to 100 mL with ultrapure water.
Store at room temperature.
10. Glycerol gelatin
25 mL of 0.2 M phosphate buffer.
50mg of sodium azide.
25 mL of glycerol.
3.8 g of gelatin.
Mix while heating to 80◦C and store at 4◦C.
11. Tris-NaCl-Tween (TNT) buffer (0.05% Tween-20 in TN
buffer)
Dilute 0.5 mL of Tween-20 in 1000 mL of TN buffer.
Store at room temperature.
N.B. The following buffers must be prepared immediately
prior to use.
12. Acetylation solution
2.4 g of triethanolamine.
1.4 g of NaCl.
Make up to 160 mL with ultrapure water.
Add 400µL of acetic anhydride just before dipping the slides.
13. 1% blocking buffer
Dissolve 1 g of Blocking Reagent (Roche Diagnostics,
Mannheim, Germany, cat.no. 11096176001) in 100 mL of
TN buffer while heating.
14. Alkaline phosphatase reaction buffer
100 mL of 1 mM Tris-HCl, pH 9.5.
5.9 g of NaCl.
4.8 g of MgCl2.
Make up to 1000 mL with ultrapure water.
15. Nitro blue tetrazolium (NBT)/5-bromo-4-chloro-3-indolyl-
phosphate (BCIP) in alkaline phosphatase reaction buffer
5 µL of NBT.
3.75 µL of BCIP.
Add 1 mL of alkaline phosphatase reaction buffer.
16. Fluorophore amplification reagent working solution
Dilute the fluorophore amplification reagent stock
solution from the tyramide signal amplification (TSA)
Plus fluorescein kit 1:50 with the 1× plus amplification
diluent, also from the kit (PerkinElmer, Waltham, MA).
Add the resulting solution to an equal amount of ultrapure
water.
17. Biotin amplification reagent working solution
Dilute the biotin amplification reagent stock solution from
the TSA Plus biotin kit 1:50 with the 1× plus amplification
diluent from the same kit (PerkinElmer).
Stepwise Procedures
Tissue Preparation
1. For fresh samples, brains were removed from the skulls of
adult mice (8–9 week old) and rapidly frozen by immersion
in isopentane that had been chilled on dry ice.
2. For fixed samples, the mice were anesthetized with sodium
pentobarbital (50 mg/kg, intraperitoneal injection), and
perfused through the left ventricle with 4% PFA. The brains
were removed, postfixed overnight at 4◦C in 4% PFA, and
cryoprotected using 20% sucrose in PBS.
3. The brain samples were cut at a thickness of 20 µm on a
cryostat (CM1520, Leica, Wetzlar, Germany) and collected
on Matsunami Adhesive Silane (MAS)-coated glass slides
(Matsunami Glass Ind., Ltd, Osaka, Japan). Coronal sections
(−1.82 mm from bregma) containing the hippocampus (Hip),
the thalamic reticular nucleus (TRN), the amygdala (Am), the
choroid plexus of the ventricles (ChP), and the central medial
nucleus of the thalamus (CM) were obtained.
RNA Probe Synthesis
1. The fluorescein-labeled probe for parvalbumin (PV) (Puig
et al., 2010) was prepared by transcribing a HindIII-linearized
plasmid using T7 RNA polymerase, Fluorescein RNA Labeling
Mix, Protector RNase Inhibitor, and DNase I recombinant
(Roche Diagnostics).
2. The RNA probes were purified using Illustra ProbeQuant
G-50 Micro Columns (GE Healthcare Japan, Tokyo, Japan).
Semi-Quantitative Reverse-Transcription (RT)-PCR
1. A brain sample from a particular brain region was punched
out from a fresh brain section using a disposable biopsy
puncher (ϕ1 mm) (Kai Medical, Gifu Japan). The punched-
out brain regions were confirmed by cresyl violet/Nissl
staining (Türeyen et al., 2004).
2. Total RNA extraction from brain samples was performed
using an miRNeasy Mini Kit (QIAGEN, Hilden, Germany)
according to the manufacturer’s instructions.
3. Total RNA (10 ng for miRNA, 200 ng for mRNA)
was reverse transcribed using a TaqManTM MicroRNA
Reverse Transcription Kit (Applied Biosystems, Foster
City, CA) for miRNA or a Moloney murine leukemia
virus reverse transcriptase (Invitrogen, Carlsbad, CA)
for mRNA.
4. Real-time RT-PCR was performed according to the
manufacturer’s instructions using either TaqManTM Universal
Master Mix II (Applied Biosystems) with miRNA-specific
TaqManTM MicroRNA Assays (Applied Biosystems, snoRNA:
Assay ID 001232; miR-34a: Assay ID 000426; miR-34c: Assay
ID 000428), or GoTaq qPCR Master Mix (Promega, Madison,
WI) with gene-specific primer sets [mouse glutamate
decarboxylase 1 (Gad1): 5′-CCT TCG CCT GCA ACC TCC
TCG AAC-3′ and 5′-GCG CAG TTT GCT CCT CCC CGT
TCT T-3′ or mouse β-actin: 5′-TCC CAC ACT GTG CCC
ATC TA-3′ and 5′-GCC ACA GGA TTC CAT ACC CA-3′].
In situ Hybridization (Outlined As a
Flowchart in Figure 1)
DAY 1
1. Desiccate sections for 10 min at 50◦C.
2. Fix the sections with 4% PFA for 15 min at room temperature,
then wash twice with PBS for 5 min.
3. Add 1 mL of proteinase K (indicated concentration) in PBS
to the section in a humidified chamber, incubate for 30
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FIGURE 1 | A flow chart of the miRNA in situ hybridization procedure.
min at 37◦C, then incubate in 4% PFA for 15 min at room
temperature, and finally rinse in distilled water.
4. Acetylate the sections in acetylation buffer for 10 min at
room temperature, then wash with PBS for 5 min at room
temperature.
5. Add 100 µL of hybridization buffer to each tissue section
and cover the section in the hybridization chamber with a
small piece of parafilm. Incubate for 30 min at the indicated
temperature.
6. For TSA detection, add 1 pmol 5′ DIG-labeled LNA probe
and 90 ng/kb fluorescein-labeled antisense PV RNA probe
to 100 µL hybridization buffer, heat for 5 min at 65◦C to
denature the probe, and then immediately chill on ice for 5
min. For NBT/BCIP detection, add 1 pmol 5′ digoxigenin
(DIG)-labeled LNA probe to 100µL hybridization buffer, heat
for 5 min at 65◦C to denature the probe, and then immediately
chill on ice for 5 min.
7. Replace the prehybridization buffer with the hybridization
buffer containing the probe and allow hybridization to take
place overnight at the temperatures calculated from the Tm-
values as indicated.
DAY 2
8. Wash sections twice with 1× SSC containing the indicated
concentrations of formamide for 10 min at the specified
hybridization temperature. Then wash sections with 0.1×
SSC for 10 min at the specified hybridization temperature
and subsequently with TN buffer for 5 min at room
temperature.
9. Quench the endogenous peroxidase activity by incubating
the sections in 3% hydrogen peroxide for 10 min, followed
by washing three times in TN buffer for 3 min. This process
is used with TSA detection.
10. Incubate sections in 1% blocking buffer for 1 h at room
temperature.
11. Incubate sections overnight with alkaline phosphatase-
labeled anti-DIG antibody (1:1000, Roche Diagnostics,
for NBT/BCIP detection), with peroxidase-labeled anti-
fluorescein antibody (1:20, Roche Diagnostics, for double
fluorescent ISH (FISH)-TSA detection in 1% blocking buffer
at 4◦C.
For Double FISH Using TSA Detection
DAY 3
12. Wash the sections three times with TNT buffer for 5 min at
room temperature.
13. Wash the sections with 1× plus amplification diluent from
the TSA Plus Fluorescein kit.
14. Pipette 100 µL fluorophore amplification reagent working
solution onto each tissue section and incubate for 20 min at
room temperature.
15. Wash the sections three times with TNT buffer for 5 min at
room temperature on a shaker.
16. Quench the endogenous peroxidase activity by incubating
the sections in 3% hydrogen peroxide for 10 min, followed
by washing three times with TN buffer for 3 min.
17. Incubate sections in 1% blocking buffer for 1 h at room
temperature.
18. Incubate sections overnight with peroxidase-labeled anti-
DIG antibody (1:250; Roche Diagnostics) in 1% blocking
buffer at 4◦C.
DAY 4
19. Wash the sections three times with TNT buffer for 5 min at
room temperature.
20. Wash the sections with 50 µL amplification diluent from the
TSA Plus biotin kit.
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21. Pipette 100µL biotin amplification reagent working solution
onto each tissue section and incubate for 10 min at room
temperature.
22. Wash the sections three times with TNT buffer for 5 min at
room temperature with gentle shaking.
23. Pipette 100 µL of Texas Red Streptavidin (3:100) and if
necessary, 10µg/mLHoechst 33258 in TNT buffer onto each
tissue section and incubate 1 h at room temperature.
24. Wash the sections three times with TNT buffer for 5 min at
room temperature with gentle shaking.
25. Mount the sections on slides with Fluoromount (Diagnostic
BioSystems, Pleasanton, CA, cat. no. K024).
26. Take images of sections using a fluorescence microscope
(Keyence filter: GFP, Ex 470/40, DM495, Em 525/50; TxRed,
Ex 560/40, DM 595, Em 630/60).
For NBT/BCIP Detection
DAY 3
12. Wash sections with 0.3% Tween 20 in maleic acid buffer four
times for 10 min.
13. Wash sections twice with alkaline phosphatase reaction
buffer for 5 min at room temperature.
14. Incubate sections in NBT/BCIP solution in alkaline
phosphatase reaction buffer for 1 h or overnight in a slide
mailer (AS ONE Corporation, Osaka, Japan) protected from
light.
15. Wash sections with PBS, pH 5.8 for 10 min at room
temperature.
If necessary, stain nuclei with 10 µg/mL hoechst 33258 in
PBS and wash twice with PBS for 5 min.
16. For long-term storage of stained samples, incubate sections
in 4% PFA for 10 min at room temperature.
17. Mount sections with glycerol gelatin and seal the slides with
nail polish.
18. Capture images using a fluorescence microscope.
ANTICIPATED RESULTS
Neuron-specific miR-124a is useful for optimizing the detection
sensitivity and performance of the miRNA ISH method in
brain tissues, since miR-124a is expressed in abundance in
the central nervous system (Deo et al., 2006). Consistent with
previous studies (Silahtaroglu et al., 2007; Sanuki et al., 2011), the
expression of miR-124a was clearly detectable in the brain using
the protocol of Silahtaroglu et al. with NBT/BCIP detection. The
miR-124a signal was detectable at hybridization temperatures of
both 22◦ and 30◦C below its RNA Tm in the Hip of the mouse
brain (Figure 2). Next, we tested LNA probes against miR-181a
and miR-34a using the same procedure as for the detection of
miR-124a. However, miR-181a and miR-34a ISH signals were
barely detectable when the hybridization temperature was set
22◦ or 30◦C below the Tm of the miRCURYTM LNA detection
probes (Figure 2). MiRNA profiles of small RNA cDNA libraries
from size-fractionated total brain RNA show that clone counts
of miR-181a and miR-34a are one-tenth and one-thirtieth of
the miR-124a clone counts, respectively (Pena et al., 2009). In
addition, we performed TaqManTM RT-PCR and showed that
the relative expression levels of miR-181a and miR-34a in the
hippocampus were one-half and one-eighth of those of miR-
124a, respectively. These data indicate that fine-tuning of the
miRNA ISH protocol is required, especially for the detection of
low-abundance miRNAs.
To increase the detection sensitivity of miRNA ISH we first
tested the influence of proteinase K digestion in PFA-perfused
fixed and fresh-frozen brain samples using LNA-modified probes
for miR-181a and miR-34a. In the TRN, which is comprised
of a thin layer of gamma-aminobutyric acid (GABA) neurons
surrounding the thalamus (Ohira et al., 2013), miR-34a was
weakly detected in fresh samples but not in PFA-fixed samples
without proteinase K treatment (Figure 3A). Proteinase K
treatment clearly enhanced the miR-34a ISH signals in both fresh
and PFA-fixed samples, although over-digestion, through the use
of 5 µg/mL proteinase K, was evident at the edges of fresh brain
samples (Figure 3A). The miR-181a signal in the Hip of fresh
samples wasmore clearly visible when compared to the PFA-fixed
samples (Figure 3B). As with the miR-34a signal, the intensity
of the miR-181a signal was enhanced by proteinase digestion
(Figure 3B). Tissue fixation prior to sectioning stabilized the
tissue against over-digestion by proteinase K but altered the
expression pattern of miR-181a in the hippocampal dentate gyrus
(DG). In the fresh sample, the miR-181a signal was clear in
the subgranular zone-granule cell layer of the hippocampal DG.
In contrast, the miR-181a signal in the PFA-fixed sample was
obscure in the subgranular zone-granule cell layer (Figure 3B).
These data suggest that proteinase digestion was effective for
detecting the ISH signal of low-abundance miRNAs in both fixed
and fresh brain samples, and that 4% PFA perfusion and/or
overnight fixation prior to sectioning of brain samples has the
potential to influence both the intensity and pattern of miRNA
ISH signals. Therefore, optimizing these parameters individually
is essential for obtaining reproducible results and detecting
miRNAs with high sensitivity.
In addition to tissue fixation and proteinase digestion,
hybridization temperature, and stringent wash conditions also
dictate the intensity and specificity of ISH signals. While Exiqon,
the manufacturer of the miRCURYTM LNA probes, recommends
hybridization at 30◦C below each RNA Tm shown in Table 1,
experimental Tm-values of LNA-modified ISH probes often do
not match the Exiqon-predicted Tm-values. In fact, among
the 148 probes examined, only 46 probes were identified as
having an experimental Tm-value within 1◦C of the putative
Tm-value (Pena et al., 2009). The difference between predicted
and experimental Tm-values ranged from −12◦ to 16.5◦C.
Therefore, we examined how hybridization temperature affects
the hybridization signals using LNA probes against miR-34a,
whose predicted Tm is 85◦C (Table 1). The miR-34a signal was
evident when the probes were hybridized at 37◦ and 48◦C,
but the signal was significantly decreased at 55◦C (Figure 4A).
When the hybridization temperature was 48◦C, the miR-34a
signal was detected mainly in the TRN. When the hybridization
temperature was 37◦C, the signal intensities for miR-34a in the
hippocampal CA and DG regions and ChP were comparable
to those in the TRN (Figure 4A). These data imply that a
hybridization temperature of 37◦C is too low to specifically detect
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FIGURE 2 | Limitation of the in situ detection of miRNA in mouse brain tissues. miRNA ISH reported by Silahtaroglu et al. (2007) was performed with
commercially available LNA-modified probes on adult mouse brain sections including the Hip and TRN at 22◦ and 30◦C below each Tm-value. miR-124a (upper
panels) was used as an example of a highly expressed miRNA in the brain. miR-181a (middle panels) and miR-34a (lower panels) were used as examples of low
abundance miRNAs in the brain. Detection was carried out using the NBT/BCIP colorimetric method. Scale bars, 500 µm.
the expression of miR-34a. Next, since formamide is widely used
as an organic solvent for ISH and can denature RNA (lowering
Tm-values), the impact of the formamide concentration in
the stringency wash buffer on signal intensity was examined.
As expected, the signal intensity for miR-34a increased in an
inversely proportional manner to the formamide concentration
(Figure 4B). The miR-34a signal in the TRN was evident when
a 50% formamide solution was used (Figure 4B). In the Hip,
a faint, non-specific ISH signal was detected when a 30%
formamide solution was used (Figure 4B). These results suggest
that stringent washing with a 50% formamide solution is most
suitable for detecting the signal specific to miR-34a.
The miR-34a expression observed in the TRN does not
exclude the possibility that the detected ISH signals may be
excessive false positive signals due to detection under low-
stringency conditions. To confirm the specificity of the miR-
34a signal, we examined the differences in the expression of
miR-34 family members (miR-34a/miR-34c, a/g caa c/t cagctaa
g/ct acactgcc a/t) using ISH and TaqManTM RT-PCR. In contrast
to the miR-34a signal, Figure 4 shows that miR-34c signals were
predominantly detected in the ChP at 49◦C, a temperature 37◦C
below its Tm (Figure 5A). Next, we performed TaqManTM RT-
PCR to assess the expression of miR-34a/c in the punched-
out tissues, including the ChP, the TRN, the Am, and the CM.
According to the ISH results, the expression of miR-34a was
highest in the TRN (Figure 5B). The miR-34a expression pattern
was similar to that of Gad1, which is an enzyme implicated
in GABA synthesis and a marker for GABAergic neurons.
Moreover, miR-34c was expressed at high levels in the ChP
(Figure 5B). The threshold cycle values of miR-34a and miR-34c
in the TRN were 25.88 ± 0.10 and 30.81 ± 0.03, respectively (n
= 3, average ± standard error). These data suggest that miRNA
ISH signals are largely reliable up to 37◦C below the Tm, and
that hybridization at 48◦C below the Tm can result in false
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FIGURE 3 | Comparisons of the signal intensities of miRNA ISH in fresh and fixed brain sections with or without proteinase K digestion. In situ detection
of miR-34a (A) and miR-181a (B) was performed in adult mouse brain sections. The hybridization temperature was 37◦C below the Tm of each RNA. Detection was
carried out using the NBT/BCIP colorimetric method. The sections were treated with or without proteinase K at the indicated concentrations. (A) Representative
images of miR-34a in fresh (upper panels) and PFA perfusion-fixed (lower panels) brain sections are shown. The insert images are a higher magnification of the boxed
brain sections including the TRN. Scale bars in (A), 1 mm; 0.2 mm in the inserted images. (B) ISH signals for miR-181a in fresh (left panels) and PFA perfusion-fixed
(right panels) brain sections are shown. The insert images are a higher magnification of the boxed brain sections including the hippocampal DG (B). Scale bars in (B),
500 µm; 100 µm in the inserted images.
positive signals. Based on these observations, the hybridization
temperature should be optimized for each individual ISH probe.
Next, to assess the robustness of this protocol for performing
miRNA ISH, we endeavored to detect the expression of three
other miRNAs, namely miR-9, miR-100, and miR-219. MiR-
9 is one of the most abundantly expressed miRNAs in the
adult brain (Malmevik et al., 2016). MiR-9 has been also been
detected in the piriform cortex and the hippocampal CA and
DG regions in the adult mouse brain (Figure 6A). In addition,
we examined the localization of miR-100 and miR-219, which
both exhibit expression levels in the brain similar to that of
miR-34a (Pena et al., 2009). MiR-100 was strongly expressed
in the subgranular zone of the DG, the hippocampal CA1
and the basolateral amygdala (Figure 6B). Since miR-100 is
upregulated in the Am by acute restraint stress, along with miR-
34a andmiR-34c (Haramati et al., 2011), the expression pattern of
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TABLE 1 | List of LNA probes and RNA Tm-values for miRNA.
miRNA name Probe sequence (5′ to 3′) Exiqon RNA Tm (
◦C) Product no. in Exiqon
miR-124a 5DigN/GGCATTCACCGCGTGCCTTA 90 88066-01
miR-181a 5DigN/ACTCACCGACAGCGTTGAATGTT 85 18066-01
miR-34a 5DigN/ACAACCAGCTAAGACACTGCCA 85 38487-01
miR-34c 5DigN/GCAATCAGCTAACTACACTGCCT 86 38542-01
miR-9 5DigN/TCATACAGCTAGATAACCAAAGA 78 18198-01
miR-100 5DigN/CACAAGTTCGGATCTACGGGTT 83 18009-01
miR-219 5DigN/AGAATTGCGTTTGGACAATCA 78 38497-01
FIGURE 4 | Adjustment of hybridization stringency for miR-34a in fresh brain tissue. ISH of miR-34a was performed in fresh samples treated with 1 µg/mL
proteinase K. (A) miR-34a probes were hybridized at the indicated temperatures (55◦, 48◦, and 37◦C) followed by washing with 50% formamide in 1× SSC at the
hybridization temperature. (B) The sections hybridized at 48◦C were washed with buffer solution including the indicated percentages of formamide (70, 50, and 30%)
in 1× SSC. The insert images are a higher magnification of the boxed brain sections including the TRN. Scale bars, 1 mm; 0.2 mm in the magnified image.
miR-100 might contribute to our understanding of its biological
function. Moreover, we showed that miR-219 was expressed
in abundance in the corpus callosum, but not in hippocampal
neurons (Figure 6C). The expression pattern also corresponded
to the function of miR-219, which regulates oligodendrocyte
differentiation (Dugas et al., 2010; Zhao et al., 2010). Thus, each
miRNA signal showed unique expression patterns in the brain,
indicating that our protocol could be applied to the in situ
detection of miRNAs of relatively low abundance in the brain.
Double FISH is useful for identifying cells expressing a
particular miRNA. Therefore, we lastly applied our protocol to
double FISH for the simultaneous detection of miRNAs and cell-
specific marker mRNAs. As described for in situ hybridization
in the Stepwise Procedures, fluorescein-labeled probes for PV, a
GABAergic interneuron marker, were hybridized in combination
with a DIG-labeled LNA probe for miR-34a. Subsequently, we
detected each probe using the TSA system in series. As shown
in Figure 7, miR-34a signals were co-localized with PV signals
in the TRN, the globus pallidus and the entopeduncular nucleus,
where GABAergic neurons are localized (Hernández et al., 2015).
ISH using the sense probe of PV mRNA did not detect any
ISH signals (data not shown). A genetically targeted miRNA
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FIGURE 5 | Validation of the specificity of the ISH signals detected.
Sections including the TRN were hybridized using LNA-modified probes
against miR-34c to test the specificity of the miR-34a ISH signal. ISH of
miR-34c was performed in fresh samples treated with 1 µg/mL proteinase K.
miR-34c probes were hybridized at 37◦ or 49◦C below the Tm-value, followed
by washing with 50% formamide in 1× SSC. (A) ISH signal of miR-34c is
shown. The brain regions including the ChP or TRN in (A) are magnified in the
right-hand panels. Scale bars, 1 mm; 0.2 mm in magnified images. (B)
Relative expression levels of Gad1 (white bars), miR-34a (gray bars), and
miR-34c (black bars) are shown in the brain regions, including the Am, CM,
ChP, or TRN, which are shown as the dotted boxed areas or boxed areas in
(A). The expression levels of mRNA and miRNA were normalized to β-actin
and snoRNA, respectively. Data are presented as the means ± SEM of three
brains.
tagging methodology has previously shown that miR-34a is
predominantly expressed in PV-positive neurons (He et al.,
2012). Consistent with that report, our protocol revealed that
miR-34a was expressed in PV-positive neurons of the mouse
brain. These results confirm that our experimental conditions can
be utilized for double FISH.
Double FISH for the simultaneous detection of miRNAs
and mRNAs also yields quantitative information about the
expression of miRNAs. For example, the proportion of the miR-
34a-expressing cells to total GABAergic neurons in the TRN
is able to be quantified. In fact, we counted the miR-34a- and
FIGURE 6 | In situ localization of miR-9, miR-100, and miR-219 in the
brain. ISH of miR-9, miR-100, and miR-219 was performed in fresh samples
treated with 1 µg/mL proteinase K. These probes were hybridized at 37◦C
below each Tm-value, followed by washing with 50% formamide in 1× SSC.
(A) Representative images show the ISH signal for miR-9 in the brain. The
higher magnification images correspond to the dotted-line and the black
rectangle in (A), the areas including the hippocampal DG and the entorhinal
cortex (EC), respectively. (B) Representative images showing the ISH signal for
miR-100 in the brain. The higher magnification images correspond to the
(Continued)
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FIGURE 6 | Continued
dotted-line and the black rectangle in (B), the areas including the hippocampal
DG and the basolateral amygdala (BLA), respectively. (C) Representative
images show the ISH signal for miR-219 in the brain. The higher magnification
images correspond to the dotted line and the black rectangle in (C), the areas
including the hippocampal DG and both the hippocampal CA1 and the corpus
callosum (cc), respectively. Scale bars, 1 mm; 0.2 mm in the magnified images.
PV-positive cells in the TRN of the section stained by double
FISH, and found that ∼85% of PV-positive neurons in the
TRN were miR-34a-expressing cells (PV positive, 276 cells;
both PV and miR-34a positive, 235 cells). Thus, double FISH
with a variety of cell-type specific markers would help to
expand our understanding about the characterization of miRNA
expression.
PITFALLS
1. Sample preparation: Brain blocks frozen brain by immersion
in isopentane chilled with dry ice can be stored at −80◦C
for at least 1 year. Moreover, sectioned samples can be stored
at−80◦C for at least a few months.
2. Prehybridization: although we usually perform this step for 30
min, the incubation time of this step can be extended for up to
an hour.
3. Hybridization: Like the prehybridization step, the reaction
time of this step can be extended for up to 1 day. Attention
must be paid to the samples, however, to prevent them from
drying out.
4. Post PFA fixation with NBT/BCIP at day 3 is carried out for
long-term storage, thus this step can be skipped.
ARTIFACTS AND TROUBLESHOOTING
1. An acetylation step was performed to reduce the background
binding of the negatively charged probe to the tissue sections.
2. Milk casein, a major component in the Blocking Reagent,
dissolves well in maleic acid buffer. Therefore, washing with
maleic acid buffer was performed to clean up excess casein,
along with excess antibodies.
3. Adequate mixing leads to uniform staining when covering
the sections with pieces of parafilm during prehybridization
and hybridization.
4. The concentration of Proteinase K used and the treatment
time applied can be modified.
5. The hybridization temperature should be optimized for each
probe.
6. Adding 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide to
the PFA fixation solution may help to increase the sensitivity
of miRNA ISH.
IF there is no signal, the following points should be
considered.
7. If the threshold cycle value of a miRNA in the punched out
tissues is greater than 28 in RT-PCR experiments, it may be
difficult to detect the ISH signals of the miRNA.
8. Since the number and position of the replacement LNA of
RNA critically affects the sensitivity of ISH signal detection,
probes with different position of the replacement LNA
of RNA may detect specific signals, although detailed
information is not provided by Exiqon.
9. In the case of FISH, the use of an incorrect fluorescence filter
will result in inadequate signal separation and produce false
positive results.
10. (Optional) In cases where miRNA ISH is combined
with immunohistochemistry, proteinase K treatment during
ISH may hinder the immunostaining due to antigen
digestion.
DISCUSSION
In this study, we detected low-abundance miRNAs when
hybridization was performed at low-stringency and washing at
high-stringency, as opposed to hybridizing at high-stringency
and washing at a similar or lower-stringency. In several protocol
papers (Zimmerman et al., 2013), hybridization was performed
using a high-stringency buffer, including 5× SSC, at no <25◦C
below its Tm-value, and low-stringency washing was performed.
High-stringency hybridization conditions are widely used to
obtain greater specificity. We detected the signal specific to
miR-34a, even with a relatively low-stringency buffer, 2× SSC,
at 37◦C below its Tm-value. The sodium concentration of 2×
SSC and 5× SSC are 0.39 and 0.975 M, respectively. According
to the nearest neighbor method, a common technique for
estimating the Tm-value, the different sodium concentrations
among these protocols corresponds to a 6.6◦C difference in Tm-
values. Therefore, the hybridization conditions in our protocol
have a relatively lower stringency than in previously reported
protocols. Since low hybridization stringency can lead to false
positive signals, the experimental conditions for each probe
should be examined, paying careful attention to stringency. Our
data, however, suggest that the detectability of miRNA ISH
can be improved by adjusting the balance of stringencies for
hybridization and washing.
Recent studies have linked miR-34a to impaired brain
function. For instance, miR-34a expression is upregulated
in patients with bipolar disorder, and the 25 predicted
targets of miR-34a, including the voltage-dependent L-
type calcium channel subunits CACNB3 and CACNA1C,
overlap with the 140 risk genes identified in genome-wide
association studies of bipolar disorder (Bavamian et al., 2015).
Additionally, miRNA expression profiling revealed that miR-
34a expression is upregulated in patients with schizophrenia
(Kim et al., 2010). miR-34a also regulates SHANK3, which
encodes synaptic scaffolding proteins associated with autism
spectrum disorders (Durand et al., 2007). In addition, we
showed that miR-34a is expressed in the interneurons of
subcortical regions. Since, the entopeduncular nucleus projects
to the lateral habenula neuronal subset, thus by innervating
aversion-encoding midbrain GABA neurons (Meye et al.,
2016), miR-34a could regulate habenula activity via a balance
between GABA and glutamate. Thus, in vivo analysis of
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FIGURE 7 | miR-34a expression in parvalbumin-positive neurons in the TRN and cortical layer V. Double FISH was performed using miR-34a and
parvalbumin (PV) probes. DIG-labeled LNA-modified probes for miR-34a and fluorescein-labeled RNA probes for PV were hybridized at 48◦C. Detection was carried
out using the TSA Plus fluorescent kit for PV (green), followed by the TSA Plus biotin kit and Texas red streptavidin for miR-34a (red). The insert images are a higher
magnification of the boxed brain areas including the TRN. EP, entopeduncular nucleus; GP, globus pallidus. Scale bars, 1 mm.
miRNA localization provides reliable and easily interpretable
information.
In general, altered miRNA expression has been linked to
psychiatric disorders, such as schizophrenia [Baudry et al.,
2010; Schizophrenia Psychiatric Genome-Wide Association
Study (GWAS) Consortium, 2011]. MiRNA-mediated epigenetic
regulation of disease risk genes may be a crucial mechanism
in psychiatric diseases. Human genetic and gene targeting
studies undertaken by us and others have suggested that
pituitary adenylate cyclase-activating polypeptide (PACAP) is
a risk factor for psychiatric disorders, such as schizophrenia
(Hashimoto et al., 2001, 2007; Ressler et al., 2011; Hazama
et al., 2014). In addition, our previous ISH studies show
in situ localization of PACAP-receptor type1 in the brain
with PAC1 ISH (Hashimoto et al., 1996), and abnormalities
in photic entrainments in PACAP-deficient mice (Kawaguchi
et al., 2010). Thus, in situ detection of miRNAs, in addition
to mRNAs, would provide direction for future functional
studies.
In summary, we focused on sample fixation, probe
accessibility and stringency in our protocol for nucleic
acid hybridization for miRNAs. We successfully detected
low-abundance miRNAs, including miR-34a, miR-34c,
miR-181a, miR-100, and miR-219, using LNA probes and
identified miRNA-expressing cells using a double FISH
technique in brain tissues. Moreover, our results revealed
that a low hybridization temperature followed by high
stringency washes might be better than previous methods
to detect miRNA signals by ISH. This method can lower the
technical hurdles in the study of spatial expression patterns
of miRNAs and the detailed roles of miRNAs in brain
function.
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